Compugen Ltd. Total Shareholders Equity 2011-2026 | CGEN

Annual Total Shareholders Equity Compugen Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
103 M	54.9 M	65.6 M	77.7 M	107 M	120 M	38.3 M	37.2 M	29.3 M	63.5 M	89.9 M	106 M	31.9 M	17.7 M	19.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
120 M	17.7 M	64.1 M

Quarterly Total Shareholders Equity Compugen Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	107 M	-	103 M	-	120 M	-	129 M	-	38.3 M	-	31.8 M	-	37.2 M	-	40.5 M	-	29.3 M	-	47.2 M	-	63.5 M	-	77.1 M	-	89.9 M	-	95.4 M	-	106 M	-	98.1 M	-	31.9 M	-	20.7 M	-	17.7 M	-	21.9 M	-	19.6 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
129 M	17.7 M	63.1 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Heron Therapeutics HRTX	14.3 M	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	789 M	$ 19.23	-1.38 %	$ 899 M	USA
Altimmune ALT	225 M	$ 3.44	2.99 %	$ 303 M	USA
Aytu BioScience AYTU	19 M	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	884 M	$ 218.06	-1.72 %	$ 5 B	Danmark
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Incyte Corporation INCY	5.17 B	$ 90.45	-0.36 %	$ 17.7 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Inovio Pharmaceuticals INO	117 M	$ 1.61	1.9 %	$ 35.7 M	USA
ARCA biopharma ABIO	382 M	-	1052.0 %	$ 415 M	USA
AgeX Therapeutics AGE	5.47 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	176 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	54.4 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	66.6 M	-	4.01 %	$ 150 M	Canada
Inventiva S.A. IVA	111 M	$ 6.08	5.19 %	$ 138 M	France
Avenue Therapeutics ATXI	2.8 M	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-16.8 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	409 M	$ 12.84	0.78 %	$ 774 M	USA
Atreca BCEL	78.4 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	188 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
KalVista Pharmaceuticals KALV	95.4 M	$ 16.6	-2.35 %	$ 824 M	Britain
Kamada Ltd. KMDA	179 M	$ 8.2	-0.61 %	$ 260 M	Israel
Calithera Biosciences CALA	8.38 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	57.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	286 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	2.53 M	-	-74.18 %	$ 955 K	USA
Karyopharm Therapeutics KPTI	-186 M	$ 6.66	-12.71 %	$ 812 K	USA
Keros Therapeutics KROS	303 M	$ 11.24	2.55 %	$ 418 M	USA
Checkpoint Therapeutics CKPT	-12.6 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	-279 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Longeveron LGVN	5.68 M	$ 0.95	-2.71 %	$ 16.7 B	USA
Denali Therapeutics DNLI	1.23 B	$ 21.09	4.56 %	$ 3.47 B	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	106 M	$ 4.42	4.25 %	$ 734 M	Canada
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA